EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN ‐Amplified Neuroblastoma

Xiaoyi Lai, Hiroyuki Yoda iD, Yuming Qiao, Yuki Kida, Keizo Takenaga iD, Yoshinao Shinozaki, Nobuko Koshikawa, Atsushi Takatori iD

Cancer Science · 2025

DOI: 10.1111/cas.70043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Xiaoyi Lai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Innovative Cancer Therapeutics, Chiba Cancer Center Research Institute, Chiba, Japan. Hauptthemen laut MEDLINE: Neuroblastoma, N-Myc Proto-Oncogene Protein, Ataxia Telangiectasia Mutated Proteins, DNA Repair. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED)-Moonshot, JSPS KAKENHI, Takeda Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amplification of MYCN is a major oncogenic driver of high‐risk neuroblastomas. We previously developed CCC ‐002, a MYCN ‐selective pyrrole‐imidazole polyamide conjugated to a DNA alkylating agent. Administration of CCC ‐002 to MYCN ‐amplified ( MYCN ‐amp) neuroblastoma cells triggered the activation of DNA damage responses. Here, we demonstrated that among the DNA damage response inhibitors, ataxia telangiectasia and Rad3‐related ( ATR ) inhibitors synergized with CCC ‐002 to suppress DNA repair‐related genes and induce apoptosis in MYCN ‐amp neuroblastoma cells. A synergistic antitumor effect was verified in an SK ‐N‐ BE (2) xenograft mouse model, in which the combined use of CCC ‐002 and ATR inhibitor at low doses significantly inhibited tumor progression. Notably, SK ‐N‐ BE (2) and SK ‐N‐ DZ cells, which showed ATM activation after CCC ‐002 treatment, exhibited high sensitivity to the combined treatment of ATR inhibitors. Comprehensive analysis of the gene expression profiles revealed that the combination treatment upregulated apoptosis‐related pathways and downregulated DNA repair‐related pathways. After the combined treatment of CCC ‐002 and ATR inhibitor, MYCN ‐amp cells showed less FISH probe signal and mRNA expression of MYCN , which was accompanied by an increase in DNA damage markers in the genomic region of MYCN , highlighting that ATR inhibitors synergize with CCC ‐002 and play a crucial role in the development of a novel MYCN ‐targeting therapy for MYCN ‐amp neuroblastoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaN-Myc Proto-Oncogene ProteinAtaxia Telangiectasia Mutated ProteinsDNA RepairNylonsHumansAnimalsCell Line, TumorMiceXenograft Model Antitumor AssaysApoptosisDrug SynergismDNA DamageGene AmplificationPyrrolesImidazolesGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

ATR inhibitionDNA damageMYCN‐amp neuroblastomaPI polyamidecombined treatment

Substanzen

N-Myc Proto-Oncogene ProteinAtaxia Telangiectasia Mutated ProteinsMYCN protein, humanATR protein, humanNylonsPyrrolesImidazoles

Autor:innen und Institutionen

  • Division of Innovative Cancer Therapeutics, Chiba Cancer Center Research Institute, Chiba, Japan.
  • Graduate School of Medical and Pharmaceutical Sciences, Chiba University, Chiba, Japan.

ORCID-Profile: Hiroyuki Yoda, Keizo Takenaga, Atsushi Takatori

Förderung

  • Japan Agency for Medical Research and Development (AMED)-Moonshot
  • JSPS KAKENHI
  • Takeda Science Foundation
  • AMED
  • JST SPRING
  • Japan Agency for Medical Research and Development

Zitieren

APA

Lai, X., Yoda, H., Qiao, Y., Kida, Y., Takenaga, K., Shinozaki, Y., Koshikawa, N., & Takatori, A. (2025). ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN ‐Amplified Neuroblastoma. Cancer Science. https://doi.org/10.1111/cas.70043

Vancouver

Lai X, Yoda H, Qiao Y, Kida Y, Takenaga K, Shinozaki Y, et al. ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN ‐Amplified Neuroblastoma. Cancer Science. 2025. doi:10.1111/cas.70043

BibTeX
@article{Lai2025,
  author = {Lai, Xiaoyi and Yoda, Hiroyuki and Qiao, Yuming and Kida, Yuki and Takenaga, Keizo and Shinozaki, Yoshinao and Koshikawa, Nobuko and Takatori, Atsushi},
  title = {ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN ‐Amplified Neuroblastoma},
  journal = {Cancer Science},
  year = {2025},
  doi = {10.1111/cas.70043}
}
Kostenlos starten →